Description
Montelukast Sodium Sachet 4mg Granules Sachets contain Montelukast Sodium, a leukotriene receptor antagonist. It is a once-daily, non-steroidal oral medication used as a preventive treatment for chronic asthma in children aged 6 months to 5 years and to relieve symptoms of allergic rhinitis (hay fever). It works by blocking the action of leukotrienes, chemical messengers that cause airway inflammation, bronchoconstriction, and allergy symptoms. The granules are designed to be mixed with a small amount of soft food and should be taken in the evening for optimal control of asthma and allergy symptoms.
Key Features
-
Active Ingredient: Each sachet contains montelukast sodium equivalent to 4 mg of montelukast, a selective and orally active leukotriene receptor antagonist.
-
Mechanism of Action: Works by blocking the action of leukotrienes, reducing inflammation in the airways and relieving allergy symptoms.
-
Primary Indications:
-
Asthma Prophylaxis: For the prevention of asthma symptoms, including day and nighttime symptoms, and for exercise-induced bronchoconstriction in children aged 2 years and older.
-
Allergic Rhinitis: For the relief of symptoms of seasonal and perennial allergic rhinitis, such as sneezing, runny nose, and nasal congestion.
-
-
Sachet Formulation: The granules are ideal for children and individuals who have difficulty swallowing tablets. They can be taken directly or mixed with a spoonful of cold or room-temperature soft food (e.g., applesauce, ice cream, carrot puree).
-
Once-Daily Dosing: For maximal efficacy, the sachet should be taken once daily in the evening, with or without food.
Technical Data Table
| Attribute | Specification |
|---|---|
| Product Name | Montiget 4mg Granules Sachets |
| Active Ingredient | Montelukast Sodium (equivalent to 4 mg montelukast) |
| Formulation | Oral granules in a sachet |
| Therapeutic Class | Leukotriene Receptor Antagonist (LTRA) |
| Indications | – Prophylaxis and chronic treatment of asthma in children (6 months to 5 years) – Relief of symptoms of allergic rhinitis (seasonal and perennial) – Prevention of exercise-induced bronchoconstriction (in children ≥2 years) |
| Mechanism of Action | Selectively inhibits the cysteinyl leukotriene receptor (CysLT1), blocking the action of leukotrienes which cause airway inflammation and bronchoconstriction |
| Route of Administration | Oral |
| Dosage | One sachet (4 mg) once daily in the evening. Can be taken directly or mixed with a spoonful of cold/room-temperature soft food (e.g., applesauce). Do not mix with liquids. Take within 15 minutes of opening the sachet. |
| Prescription Status | Prescription Only Medicine (POM) |
| Storage | Store in a cool, dry place below 25°C, away from light and moisture. |
Reviews
There are no reviews yet.